Fluorescent In Situ Hybridization (FISH) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Fluorescent In Situ Hybridization (FISH) General Information

Description

Certain technology with applications in prenatal diagnosis of congenital disorders. The technology is based on hybridization in which a DNA probe is labeled with fluorescent dye so that it can be seen with a microscope.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Acquirer
China Medical Technologies
Corporate Office
  • British Virgin Islands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fluorescent In Situ Hybridization (FISH) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Fluorescent In Situ Hybridization (FISH)‘s full profile, request access.

Request a free trial

Fluorescent In Situ Hybridization (FISH) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Fluorescent In Situ Hybridization (FISH)‘s full profile, request access.

Request a free trial

Fluorescent In Situ Hybridization (FISH) FAQs

  • Where is Fluorescent In Situ Hybridization (FISH) headquartered?

    Fluorescent In Situ Hybridization (FISH) is headquartered in British Virgin Islands.

  • What industry is Fluorescent In Situ Hybridization (FISH) in?

    Fluorescent In Situ Hybridization (FISH)’s primary industry is Buildings and Property.

  • Is Fluorescent In Situ Hybridization (FISH) a private or public company?

    Fluorescent In Situ Hybridization (FISH) is a Private company.

  • What is the current valuation of Fluorescent In Situ Hybridization (FISH)?

    The current valuation of Fluorescent In Situ Hybridization (FISH) is 00000.

  • What is Fluorescent In Situ Hybridization (FISH)’s current revenue?

    The current revenue for Fluorescent In Situ Hybridization (FISH) is 000000.

  • Who are Fluorescent In Situ Hybridization (FISH)’s investors?

    Molecular Diagnostics Technologies and Supreme Well Investments have invested in Fluorescent In Situ Hybridization (FISH).

  • When was Fluorescent In Situ Hybridization (FISH) acquired?

    Fluorescent In Situ Hybridization (FISH) was acquired on 01-Mar-2007.

  • Who acquired Fluorescent In Situ Hybridization (FISH)?

    Fluorescent In Situ Hybridization (FISH) was acquired by China Medical Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »